The Vietnam clinical diagnostics market reached USD 434.50 Million in 2024 and is projected to grow to USD 765.73 Million by 2033, with a CAGR of 5.83% during the forecast period 2025-2033. Growth is driven by increased healthcare infrastructure investments, government support, and rising adoption of digital health and AI technologies, alongside a focus on infectious disease testing and preventive medicine. These factors boost demand for advanced diagnostics in both public and private healthcare sectors. 

Study Assumption Years

  • Base Year: 2024
  • Historical Year/Period: 2019-2024
  • Forecast Year/Period: 2025-2033

Vietnam Clinical Diagnostics Market Key Takeaways

  • Current Market Size: USD 434.50 Million in 2024
  • CAGR: 5.83% (2025-2033)
  • Forecast Period: 2025-2033
  • Vietnam's healthcare sector is undergoing rapid growth fueled by substantial government investment and infrastructure development.
  • Government incentives such as tax breaks and subsidies were introduced in 2024 to address diagnostic facility shortages in rural areas.
  • Integration of AI and digital health technologies, like Fujifilm's NURA center, is advancing diagnostic capabilities nationwide.
  • Focus on infectious disease testing and preventive healthcare is escalating due to public health campaigns and expanding insurance coverage.
  • The National Health Insurance Program covers over 93% of the population, broadening access to advanced diagnostic services.

Sample Request Link: https://www.imarcgroup.com/vietnam-clinical-diagnostics-market/requestsample

Market Growth Factors

The growth of Vietnam's clinical diagnostics market is significantly supported by expanding healthcare infrastructure and government investment. In 2024, the government introduced comprehensive incentives including tax breaks and subsidies aimed at establishing new clinical laboratories, especially targeting rural areas with diagnostic shortages. These initiatives are designed to alleviate healthcare disparities and enhance the nation's healthcare capacity. The country also benefits from international aid through loans and medical equipment donations from organizations such as the World Bank and the European Union. Large-scale hospital upgrades and new construction projects approved by the central government further stimulate demand for diagnostic services in both public and private sectors.

The market is also driven by the integration of digital health and artificial intelligence technologies. In July 2024, Fujifilm inaugurated the NURA health screening center in Hanoi, which marks a pivotal step in improving diagnostic infrastructure. Public hospitals outsourcing digital system development to local IT firms and the adoption of AI-powered diagnostic tools, automated laboratory systems, and cloud-based analytics facilitate real-time result sharing and population health monitoring. Telemedicine services, accelerated by the COVID-19 pandemic, extend remote diagnostic capabilities to rural and remote regions, increasing accessibility and operational efficiency in healthcare delivery.

A strong focus on infectious disease testing and preventive healthcare is another critical growth factor. Vietnam faces a high burden of communicable diseases such as tuberculosis and dengue fever, alongside rising non-communicable diseases like diabetes and cardiovascular conditions. Government public health campaigns have increased routine diagnostic testing, particularly among at-risk groups. Additionally, the National Health Insurance Program, covering 93.35% of the population, expands access to a wide range of diagnostic services, including advanced laboratory tests. These efforts collectively drive demand for comprehensive diagnostic testing capabilities nationwide.

Market Segmentation

Test Insights:

  • Lipid Panel: Analysis of blood lipids to monitor cardiovascular health.
  • Liver Panel: Tests to evaluate liver function and detect liver diseases.
  • Renal Panel: Assessment of kidney function through specific biomarkers.
  • Complete Blood Count: Comprehensive blood test evaluating overall health.
  • Electrolyte Testing: Measurement of electrolyte levels critical for body functions.
  • Infectious Disease Testing: Detection and monitoring of infectious agents.
  • Others: Additional tests supporting diagnostic needs.

Product Insights:

  • Instruments: Diagnostic equipment and devices used for testing.
  • Reagents: Chemical substances used in diagnostic assays.
  • Others: Supplementary products related to clinical diagnostics.

End User Insights:

  • Hospital Laboratory: Diagnostic services provided within hospital settings.
  • Diagnostic Laboratory: Independent labs offering diagnostic tests.
  • Point-of-care Testing: Rapid diagnostic tests conducted near patients.
  • Others: Additional end-user categories involved in diagnostics.

Regional Insights

The Vietnam clinical diagnostics market is segmented into Northern Vietnam, Central Vietnam, and Southern Vietnam. The report does not specify the dominant region or provide exact market share or CAGR per region. Thus, specific regional dominance and statistics are not provided in the source.

Recent Developments & News

In December 2024, CarePlus International Clinics launched a state-of-the-art Diagnostic Imaging Center in Ho Chi Minh City’s District 1, offering MRI and CT scan services enhanced with advanced AI technology. The center also provides comprehensive health packages including stroke, cardiac, and cancer screenings accessible via the CarePlus Vietnam app for seamless patient experience.

In August 2024, VinBrain partnered with Medlatec, one of the largest private healthcare systems in Vietnam, to implement its DrAid AI platform across Medlatec’s hospitals and clinics network, advancing AI-powered medical imaging diagnostics and improving patient access to cutting-edge healthcare technology.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=42777&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302